Abstract CT150: A first-in-human phase I study of the OX40 agonist GSK3174998 (GSK998) +/- pembrolizumab in patients (Pts) with selected advanced solid tumors (ENGAGE-1)

Name: Work Video:
Duration: 3 min 30 s
Sophie Postel‐Vinay; Vincent K. Lam; Willeke Ros; Todd M. Bauer; Aaron R. Hansen; Daniel C. Cho; F. Stephen Hodi; Jan H.M. Schellens; Jennifer K. Litton; Sandrine Aspeslagh; Karen A. Autio; Frans L. Opdam; Meredith McKean; Neeta Somaiah; Stéphane Champiat; Mehmet Altan; Anna Spreafico; Osama E. Rahma; Elaine Paul; Christoph M. Ahlers; Helen Zhou; Herbert Struemper; Shelby A. Gorman; Maura Watmuff; Kaitlin Yablonski; Niranjan Yanamandra; Michael Chisamore; Emmett V. Schmidt; Axel Hoos; Aurélien Marabelle; Jeffrey S. Weber; John V. Heymach
{'id': 'https://openalex.org/W3083498943', 'doi': 'https://doi.org/10.1158/1538-7445.am2020-ct150', 'title': 'Abstract CT150: A first-in-human phase I study of the OX40 agonist GSK3174998 (GSK998) +/- pembrolizumab in patients (Pts) with selected advanced solid tumors (ENGAGE-1)', 'display_name': 'Abstract CT150: A first-in-human phase I study of the OX40 agonist GSK3174998 (GSK998) +/- pembrolizumab in patients (Pts) with selected advanced solid tumors (ENGAGE-1)', 'publication_year': 2020, 'publication_date': '2020-08-15', 'ids': {'openalex': 'https://openalex.org/W3083498943', 'doi': 'https://doi.org/10.1158/1538-7445.am2020-ct150', 'mag': '3083498943'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2020-ct150', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5008444865', 'display_name': 'Sophie Postel‐Vinay', 'orcid': 'https://orcid.org/0000-0001-5562-1857'}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Sophie Postel-Vinay', 'raw_affiliation_strings': ['1Gustave Roussy, Villejuif, France;'], 'affiliations': [{'raw_affiliation_string': '1Gustave Roussy, Villejuif, France;', 'institution_ids': ['https://openalex.org/I2801843802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063752111', 'display_name': 'Vincent K. Lam', 'orcid': 'https://orcid.org/0000-0002-1319-2588'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vincent K. Lam', 'raw_affiliation_strings': ['2The University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '2The University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014113942', 'display_name': 'Willeke Ros', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Willeke Ros', 'raw_affiliation_strings': ['3Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;'], 'affiliations': [{'raw_affiliation_string': '3Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;', 'institution_ids': ['https://openalex.org/I2898336195']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037195922', 'display_name': 'Todd M. Bauer', 'orcid': 'https://orcid.org/0000-0002-3078-5043'}, 'institutions': [{'id': 'https://openalex.org/I4210100810', 'display_name': 'Sarah Cannon', 'ror': 'https://ror.org/014t21j89', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210100810']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Todd M. Bauer', 'raw_affiliation_strings': ['4Sarah Cannon Research Institute/TN Oncology, Nashville, TN;'], 'affiliations': [{'raw_affiliation_string': '4Sarah Cannon Research Institute/TN Oncology, Nashville, TN;', 'institution_ids': ['https://openalex.org/I4210100810']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022267545', 'display_name': 'Aaron R. Hansen', 'orcid': 'https://orcid.org/0000-0002-2363-8707'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Aaron R. Hansen', 'raw_affiliation_strings': ['5Princess Margaret Cancer Centre, Toronto, Ontario, Canada;'], 'affiliations': [{'raw_affiliation_string': '5Princess Margaret Cancer Centre, Toronto, Ontario, Canada;', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083614176', 'display_name': 'Daniel C. Cho', 'orcid': 'https://orcid.org/0000-0002-4248-6382'}, 'institutions': [{'id': 'https://openalex.org/I4210086933', 'display_name': 'NYU Langone Health', 'ror': 'https://ror.org/005dvqh91', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210086933']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel C. Cho', 'raw_affiliation_strings': ['6Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY;'], 'affiliations': [{'raw_affiliation_string': '6Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY;', 'institution_ids': ['https://openalex.org/I4210086933']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084967339', 'display_name': 'F. Stephen Hodi', 'orcid': 'https://orcid.org/0000-0001-6825-091X'}, 'institutions': [{'id': 'https://openalex.org/I4210117453', 'display_name': 'Dana-Farber Cancer Institute', 'ror': 'https://ror.org/02jzgtq86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210117453']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'F. Stephen Hodi', 'raw_affiliation_strings': ['7Dana-Farber Cancer Institute, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '7Dana-Farber Cancer Institute, Boston, MA;', 'institution_ids': ['https://openalex.org/I4210117453']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000418012', 'display_name': 'Jan H.M. Schellens', 'orcid': 'https://orcid.org/0000-0001-6832-1976'}, 'institutions': [{'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Jan H.M. Schellens', 'raw_affiliation_strings': ['3Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;'], 'affiliations': [{'raw_affiliation_string': '3Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;', 'institution_ids': ['https://openalex.org/I2898336195']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014713051', 'display_name': 'Jennifer K. Litton', 'orcid': 'https://orcid.org/0000-0001-8390-4985'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jennifer K. Litton', 'raw_affiliation_strings': ['2The University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '2The University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063737641', 'display_name': 'Sandrine Aspeslagh', 'orcid': 'https://orcid.org/0000-0001-6598-9161'}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Sandrine Aspeslagh', 'raw_affiliation_strings': ['1Gustave Roussy, Villejuif, France;'], 'affiliations': [{'raw_affiliation_string': '1Gustave Roussy, Villejuif, France;', 'institution_ids': ['https://openalex.org/I2801843802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090778997', 'display_name': 'Karen A. Autio', 'orcid': 'https://orcid.org/0000-0003-0720-0390'}, 'institutions': [{'id': 'https://openalex.org/I39965400', 'display_name': 'Kettering University', 'ror': 'https://ror.org/03rcspa57', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I39965400']}, {'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Karen A. Autio', 'raw_affiliation_strings': ['8Memorial Sloan Kettering Cancer Center, New York, NY;'], 'affiliations': [{'raw_affiliation_string': '8Memorial Sloan Kettering Cancer Center, New York, NY;', 'institution_ids': ['https://openalex.org/I39965400', 'https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011048678', 'display_name': 'Frans L. Opdam', 'orcid': 'https://orcid.org/0000-0002-9489-6535'}, 'institutions': [{'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Frans L. Opdam', 'raw_affiliation_strings': ['3Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;'], 'affiliations': [{'raw_affiliation_string': '3Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands;', 'institution_ids': ['https://openalex.org/I2898336195']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002575629', 'display_name': 'Meredith McKean', 'orcid': 'https://orcid.org/0000-0003-0944-7418'}, 'institutions': [{'id': 'https://openalex.org/I4210100810', 'display_name': 'Sarah Cannon', 'ror': 'https://ror.org/014t21j89', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210100810']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Meredith McKean', 'raw_affiliation_strings': ['4Sarah Cannon Research Institute/TN Oncology, Nashville, TN;'], 'affiliations': [{'raw_affiliation_string': '4Sarah Cannon Research Institute/TN Oncology, Nashville, TN;', 'institution_ids': ['https://openalex.org/I4210100810']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087234749', 'display_name': 'Neeta Somaiah', 'orcid': 'https://orcid.org/0000-0002-0146-7732'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Neeta Somaiah', 'raw_affiliation_strings': ['2The University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '2The University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060793722', 'display_name': 'Stéphane Champiat', 'orcid': 'https://orcid.org/0000-0002-0741-2118'}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Stephane Champiat', 'raw_affiliation_strings': ['1Gustave Roussy, Villejuif, France;'], 'affiliations': [{'raw_affiliation_string': '1Gustave Roussy, Villejuif, France;', 'institution_ids': ['https://openalex.org/I2801843802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039160380', 'display_name': 'Mehmet Altan', 'orcid': 'https://orcid.org/0000-0001-9229-156X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mehmet Altan', 'raw_affiliation_strings': ['2The University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '2The University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088186975', 'display_name': 'Anna Spreafico', 'orcid': 'https://orcid.org/0000-0002-3034-3042'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Anna Spreafico', 'raw_affiliation_strings': ['5Princess Margaret Cancer Centre, Toronto, Ontario, Canada;'], 'affiliations': [{'raw_affiliation_string': '5Princess Margaret Cancer Centre, Toronto, Ontario, Canada;', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080783554', 'display_name': 'Osama E. Rahma', 'orcid': 'https://orcid.org/0000-0001-7302-5805'}, 'institutions': [{'id': 'https://openalex.org/I4210117453', 'display_name': 'Dana-Farber Cancer Institute', 'ror': 'https://ror.org/02jzgtq86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210117453']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Osama Rahma', 'raw_affiliation_strings': ['7Dana-Farber Cancer Institute, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '7Dana-Farber Cancer Institute, Boston, MA;', 'institution_ids': ['https://openalex.org/I4210117453']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027768129', 'display_name': 'Elaine Paul', 'orcid': 'https://orcid.org/0000-0002-2975-2316'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elaine M. Paul', 'raw_affiliation_strings': ['9GlaxoSmithKline, Research Triangle Park, NC;'], 'affiliations': [{'raw_affiliation_string': '9GlaxoSmithKline, Research Triangle Park, NC;', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052046806', 'display_name': 'Christoph M. Ahlers', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christoph M. Ahlers', 'raw_affiliation_strings': ['10GlaxoSmithKline, Collegeville, PA;'], 'affiliations': [{'raw_affiliation_string': '10GlaxoSmithKline, Collegeville, PA;', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101647354', 'display_name': 'Helen Zhou', 'orcid': 'https://orcid.org/0009-0007-8538-1234'}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Helen Zhou', 'raw_affiliation_strings': ['10GlaxoSmithKline, Collegeville, PA;'], 'affiliations': [{'raw_affiliation_string': '10GlaxoSmithKline, Collegeville, PA;', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001241842', 'display_name': 'Herbert Struemper', 'orcid': 'https://orcid.org/0000-0003-3011-1572'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Herbert Struemper', 'raw_affiliation_strings': ['9GlaxoSmithKline, Research Triangle Park, NC;'], 'affiliations': [{'raw_affiliation_string': '9GlaxoSmithKline, Research Triangle Park, NC;', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081415754', 'display_name': 'Shelby A. Gorman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Shelby A. Gorman', 'raw_affiliation_strings': ['10GlaxoSmithKline, Collegeville, PA;'], 'affiliations': [{'raw_affiliation_string': '10GlaxoSmithKline, Collegeville, PA;', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082495621', 'display_name': 'Maura Watmuff', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Maura Watmuff', 'raw_affiliation_strings': ['10GlaxoSmithKline, Collegeville, PA;'], 'affiliations': [{'raw_affiliation_string': '10GlaxoSmithKline, Collegeville, PA;', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036068419', 'display_name': 'Kaitlin Yablonski', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kaitlin M. Yablonski', 'raw_affiliation_strings': ['10GlaxoSmithKline, Collegeville, PA;'], 'affiliations': [{'raw_affiliation_string': '10GlaxoSmithKline, Collegeville, PA;', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059937355', 'display_name': 'Niranjan Yanamandra', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Niranjan Yanamandra', 'raw_affiliation_strings': ['10GlaxoSmithKline, Collegeville, PA;'], 'affiliations': [{'raw_affiliation_string': '10GlaxoSmithKline, Collegeville, PA;', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038887077', 'display_name': 'Michael Chisamore', 'orcid': 'https://orcid.org/0009-0006-8629-8232'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'Merck & Co., Inc., Rahway, NJ, USA (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael J. Chisamore', 'raw_affiliation_strings': ['11Merck & Co., Inc, Kenilworth, NJ.'], 'affiliations': [{'raw_affiliation_string': '11Merck & Co., Inc, Kenilworth, NJ.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042503296', 'display_name': 'Emmett V. Schmidt', 'orcid': 'https://orcid.org/0000-0003-4687-9367'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'Merck & Co., Inc., Rahway, NJ, USA (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Emmett V. Schmidt', 'raw_affiliation_strings': ['11Merck & Co., Inc, Kenilworth, NJ.'], 'affiliations': [{'raw_affiliation_string': '11Merck & Co., Inc, Kenilworth, NJ.', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086481435', 'display_name': 'Axel Hoos', 'orcid': 'https://orcid.org/0000-0001-5269-9376'}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Axel Hoos', 'raw_affiliation_strings': ['10GlaxoSmithKline, Collegeville, PA;'], 'affiliations': [{'raw_affiliation_string': '10GlaxoSmithKline, Collegeville, PA;', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065206480', 'display_name': 'Aurélien Marabelle', 'orcid': 'https://orcid.org/0000-0002-5816-3019'}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Aurélien Marabelle', 'raw_affiliation_strings': ['1Gustave Roussy, Villejuif, France;'], 'affiliations': [{'raw_affiliation_string': '1Gustave Roussy, Villejuif, France;', 'institution_ids': ['https://openalex.org/I2801843802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047177507', 'display_name': 'Jeffrey S. Weber', 'orcid': 'https://orcid.org/0000-0002-4962-2957'}, 'institutions': [{'id': 'https://openalex.org/I4210086933', 'display_name': 'NYU Langone Health', 'ror': 'https://ror.org/005dvqh91', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210086933']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jeffrey S. Weber', 'raw_affiliation_strings': ['6Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY;'], 'affiliations': [{'raw_affiliation_string': '6Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY;', 'institution_ids': ['https://openalex.org/I4210086933']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5048380048', 'display_name': 'John V. Heymach', 'orcid': 'https://orcid.org/0000-0001-9068-8942'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John V. Heymach', 'raw_affiliation_strings': ['2The University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '2The University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 4, 'institutions_distinct_count': 12, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.903, 'has_fulltext': False, 'cited_by_count': 21, 'citation_normalized_percentile': {'value': 0.999965, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '80', 'issue': '16_Supplement', 'first_page': 'CT150', 'last_page': 'CT150'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10580', 'display_name': 'Immunotherapy and Immune Responses', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9759, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8179867}, {'id': 'https://openalex.org/C2780057760', 'wikidata': 'https://www.wikidata.org/wiki/Q13896859', 'display_name': 'Pembrolizumab', 'level': 4, 'score': 0.75352156}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.57307816}, {'id': 'https://openalex.org/C2778570526', 'wikidata': 'https://www.wikidata.org/wiki/Q653197', 'display_name': 'Rash', 'level': 2, 'score': 0.46042323}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.44942284}, {'id': 'https://openalex.org/C2777472916', 'wikidata': 'https://www.wikidata.org/wiki/Q1164529', 'display_name': 'Renal cell carcinoma', 'level': 2, 'score': 0.42789698}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.42533273}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.42406327}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.42278203}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.36319506}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.32091963}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.26586315}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2020-ct150', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.86, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4377231915', 'https://openalex.org/W4288033734', 'https://openalex.org/W3037068108', 'https://openalex.org/W3031648790', 'https://openalex.org/W2585407512', 'https://openalex.org/W2409418055', 'https://openalex.org/W2029542266', 'https://openalex.org/W2020995501', 'https://openalex.org/W2011188477', 'https://openalex.org/W2002891289'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'OX40': [2, 24, 57, 328, 337, 399, 411, 428, 540], 'is': [3, 52, 63], 'a': [4, 48, 53, 64, 139, 220, 319], 'costimulatory': [5], 'receptor': [6, 217], 'transiently': [7], 'expressed': [8], 'on': [9, 313], 'the': [10, 114, 210, 226, 236, 397, 432, 539, 559, 563], 'surface': [11], 'of': [12, 77, 113, 150, 222, 327, 361, 410, 416, 434, 538, 558, 562], 'activated': [13], 'T': [14], 'cells': [15, 20, 333], 'and': [16, 33, 74, 86, 116, 132, 143, 200, 216, 240, 250, 258, 268, 280, 317, 324, 390, 402, 430, 440, 443, 573], 'some': [17, 350, 386, 391], 'innate': [18], 'immune': [19], '(e.g.': [21], 'NK': [22], 'cells).': [23], 'agonists': [25, 442], 'have': [26], 'been': [27], 'shown': [28], 'to': [29], 'increase': [30], 'antitumor': [31], 'immunity': [32], 'improve': [34], 'tumor-free': [35], 'survival': [36], 'in': [37, 45, 87, 97, 170, 209, 247, 252, 264, 334, 349, 385, 546], 'preclinical': [38, 403], 'models,': [39], 'demonstrating': [40], 'increased': [41, 345, 406], 'efficacy': [42, 433], 'when': [43], 'given': [44], 'combination': [46, 88, 370], 'with': [47, 89, 99, 298, 308, 359, 392, 438, 549], 'PD-1': [49], 'inhibitor.': [50], 'GSK998': [51, 78, 205, 353, 417], 'humanized': [54], 'IgG1': [55], 'agonistic': [56], 'monoclonal': [58], 'antibody.': [59], 'Methods:': [60], 'ENGAGE-1': [61], '(NCT02528357)': [62], 'Phase': [65], '1': [66, 272, 275], 'dose': [67, 221, 238], 'escalation': [68, 137], 'study': [69, 537], 'evaluating': [70], 'safety,': [71], 'PK,': [72], 'PD,': [73], 'clinical': [75, 245, 293, 365, 414], 'activity': [76, 366, 409], '(0.003-10': [79], 'mg/kg': [80, 224], 'IV': [81, 93], 'Q3W)': [82], 'alone': [83], '(Part': [84, 95, 198, 203], '1)': [85, 199], 'pembrolizumab': [90, 355, 380, 545], '200': [91], 'mg': [92], 'Q3W': [94], '2)': [96], 'pts': [98, 152, 389], 'previously': [100], 'treated': [101], 'advanced': [102, 551], 'solid': [103, 552], 'tumors:': [104], 'non-small': [105], 'cell': [106, 111, 119, 425], 'lung': [107], 'cancer': [108], '(NSCLC),': [109], 'squamous': [110], 'carcinoma': [112], 'head': [115], 'neck,': [117], 'renal': [118], 'carcinoma,': [120], 'melanoma': [121], '(MEL),': [122], 'bladder': [123], 'cancer,': [124, 131], 'soft': [125], 'tissue': [126], 'sarcoma': [127], '(STS),': [128], 'triple-negative': [129], 'breast': [130], 'MSI-high': [133], 'colorectal': [134], 'carcinoma.': [135], 'Dose': [136], 'used': [138], 'continuous': [140], 'reassessment': [141], 'method': [142], '4-week': [144], 'DLT': [145], 'period.': [146], 'Results:': [147], 'A': [148, 533], 'total': [149, 332], '138': [151], 'were': [153, 195, 262, 295, 336, 383], 'enrolled': [154], '(45': [155], 'Part': [156, 159, 165, 171, 253, 271, 281, 291], '1,': [157], '96': [158], '2;': [160], '3': [161], 'crossed': [162], 'over': [163, 235], 'from': [164, 341], '1).': [166], 'Two': [167], 'DLTs': [168], 'occurred': [169], '2': [172, 254, 282, 292], 'only': [173], '(G3': [174], 'non-malignant': [175], 'pleural': [176], 'effusion': [177], '0.03': [178], 'mg/kg;': [179], 'G1': [180], 'myocarditis': [181], '10': [182], 'mg/kg);': [183, 290], 'MTD': [184], 'was': [185, 225, 241, 329, 356, 367], 'not': [186, 296, 373], 'established.': [187], 'Most': [188], 'common': [189], '(≥10%)': [190], 'treatment-related': [191], 'AEs': [192], '(mostly': [193], 'G1-2)': [194], 'diarrhea,': [196], 'fatigue': [197], 'fatigue,': [201], 'nausea': [202], '2).': [204], 'demonstrated': [206], 'target': [207, 362], 'engagement': [208], 'periphery': [211], 'as': [212], 'evidenced': [213], 'by': [214], 'PK': [215, 230], 'occupancy': [218], '(RO);': [219], '0.3': [223, 278], 'threshold': [227], 'for': [228, 243, 379, 566], 'linear': [229], '&amp;': [231], 'peripheral': [232, 323], 'RO': [233], 'saturation': [234], '3-wk': [237], 'interval': [239], 'selected': [242, 550], 'further': [244], 'evaluation': [246, 415], 'MEL,': [248], 'STS,': [249], 'NSCLC': [251], 'expansion.': [255], 'Clinical': [256], 'responses': [257, 294, 371, 382], 'SD': [259], '≥24': [260], 'weeks': [261], 'observed': [263, 384, 401], 'both': [265, 277], 'PD-1/L1': [266, 387], 'naïve': [267], 'experienced': [269, 388], 'pts:': [270], '(1': [273], 'PR,': [274, 286], 'SD;': [276, 288], 'mg/kg)': [279], '(2': [283], 'CR,': [284], '7': [285], '9': [287], '0.01-3': [289], 'correlated': [297], 'baseline': [299], 'tumor': [300, 325, 335, 342], 'PD-L1': [301, 309, 394], 'expression': [302, 326, 400, 407, 429], 'levels;': [303], 'including': [304], 'one': [305], 'MEL': [306], 'pt': [307], 'TPS=0': [310], 'who': [311], 'progressed': [312], 'prior': [314], 'CTLA-4/PD-1': [315], 'treatment': [316], 'had': [318], 'CR': [320], '(&amp;gt;18mo).': [321], 'Overall,': [322], 'low': [330, 393, 398], '(&amp;lt;2%': [331], '+ve).': [338], 'MultiOmyxTM': [339], 'data': [340], 'biopsies': [343], 'suggested': [344], 'NK/decreased': [346], 'Treg': [347], 'involvement': [348], 'responders.': [351], 'Conclusions:': [352], '+/-': [354, 544], 'well': [357], 'tolerated,': [358], 'evidence': [360, 404], 'engagement;': [363], 'monotherapy': [364], 'limited.': [368], 'While': [369], 'may': [372], 'be': [374], 'significantly': [375], 'greater': [376], 'than': [377], 'expected': [378], 'alone,': [381], 'expression.': [395], 'Given': [396], 'that': [405], 'improves': [408], 'agonism,': [412], 'ongoing': [413], 'will': [418], 'assess': [419], 'whether': [420], 'concurrent': [421], 'immune-stimulation': [422], 'or': [423], 'immunogenic': [424], 'death': [426], 'impacts': [427], 'increases': [431], 'this': [435], 'agent.': [436], 'Combinations': [437], 'TLR4': [439], 'ICOS': [441], 'an': [444], 'anti-BCMA': [445], 'antibody-drug': [446], 'conjugate': [447], 'are': [448], 'ongoing.': [449], 'Citation': [450], 'Format:': [451], 'Sophie': [452], 'Postel-Vinay,': [453], 'Vincent': [454], 'K.': [455, 475], 'Lam,': [456], 'Willeke': [457], 'Ros,': [458], 'Todd': [459], 'M.': [460, 498, 501, 513], 'Bauer,': [461], 'Aaron': [462], 'R.': [463], 'Hansen,': [464], 'Daniel': [465], 'C.': [466], 'Cho,': [467], 'F.': [468], 'Stephen': [469], 'Hodi,': [470], 'Jan': [471], 'H.M.': [472], 'Schellens,': [473], 'Jennifer': [474], 'Litton,': [476], 'Sandrine': [477], 'Aspeslagh,': [478], 'Karen': [479], 'A.': [480, 508], 'Autio,': [481], 'Frans': [482], 'L.': [483], 'Opdam,': [484], 'Meredith': [485], 'McKean,': [486], 'Neeta': [487], 'Somaiah,': [488], 'Stephane': [489], 'Champiat,': [490], 'Mehmet': [491], 'Altan,': [492], 'Anna': [493], 'Spreafico,': [494], 'Osama': [495], 'Rahma,': [496], 'Elaine': [497], 'Paul,': [499], 'Christoph': [500], 'Ahlers,': [502], 'Helen': [503], 'Zhou,': [504], 'Herbert': [505], 'Struemper,': [506], 'Shelby': [507], 'Gorman,': [509], 'Maura': [510], 'Watmuff,': [511], 'Kaitlin': [512], 'Yablonski,': [514], 'Niranjan': [515], 'Yanamandra,': [516], 'Michael': [517], 'J.': [518], 'Chisamore,': [519], 'Emmett': [520], 'V.': [521, 531], 'Schmidt,': [522], 'Axel': [523], 'Hoos,': [524], 'Aurélien': [525], 'Marabelle,': [526], 'Jeffrey': [527], 'S.': [528], 'Weber,': [529], 'John': [530], 'Heymach.': [532], 'first-in-human': [534], 'phase': [535], 'I': [536], 'agonist': [541], 'GSK3174998': [542], '(GSK998)': [543], 'patients': [547], '(Pts)': [548], 'tumors': [553], '(ENGAGE-1)': [554], '[abstract].': [555], 'In:': [556], 'Proceedings': [557], 'Annual': [560], 'Meeting': [561], 'American': [564], 'Association': [565], 'Cancer': [567, 579], 'Research': [568], '2020;': [569], '2020': [570], 'Apr': [571], '27-28': [572], 'Jun': [574], '22-24.': [575], 'Philadelphia': [576], '(PA):': [577], 'AACR;': [578], 'Res': [580], '2020;80(16': [581], 'Suppl):Abstract': [582], 'nr': [583], 'CT150.': [584]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3083498943', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 7}, {'year': 2020, 'cited_by_count': 1}], 'updated_date': '2025-01-13T08:27:59.514008', 'created_date': '2020-09-11'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
